APA (7th ed.) Citation

LS, H., M, S., TJ, K., L, K., O, R., N, G., . . . S, C. (2026). Reply to "Dynamic Susceptibility Contrast MRI for Evaluation of Patients With High-Grade Glioma: Need for Multicenter Clinical Trial Validation". AJR. American journal of roentgenology, 226(1), e2533122. https://doi.org/10.2214/AJR.25.33122

Chicago Style (17th ed.) Citation

LS, Hu, Smits M, Kaufmann TJ, Knutsson L, Rapalino O, Galldiks N, Sundgren PC, and Cha S. "Reply to "Dynamic Susceptibility Contrast MRI for Evaluation of Patients With High-Grade Glioma: Need for Multicenter Clinical Trial Validation"." AJR. American Journal of Roentgenology 226, no. 1 (2026): e2533122. https://doi.org/10.2214/AJR.25.33122.

MLA (9th ed.) Citation

LS, Hu, et al. "Reply to "Dynamic Susceptibility Contrast MRI for Evaluation of Patients With High-Grade Glioma: Need for Multicenter Clinical Trial Validation"." AJR. American Journal of Roentgenology, vol. 226, no. 1, 2026, p. e2533122, https://doi.org/10.2214/AJR.25.33122.